FDG-PET/CT in high-risk primary breast cancer: A prospective study of stage migration and clinical impact

被引：0
|
作者：
Vogsen, M. [1 ]
Jensen, J. D. [1 ]
Christensen, I. Y. [2 ]
Gerke, O. [3 ]
Jylling, A. M. B. [4 ]
Larsen, L. B. [2 ]
Braad, P-E. [3 ]
Soe, K. L. [5 ]
Bille, C. [5 ]
Ewertz, M. [6 ]
Hildebrandt, M. G. [3 ]
机构：
[1] Odense Univ Hosp, Dept Oncol, Odense, Denmark
[2] Odense Univ Hosp, Dept Radiol, Odense, Denmark
[3] Odense Univ Hosp, Dept Nucl Med, Odense, Denmark
[4] Odense Univ Hosp, Dept Pathol, Odense, Denmark
[5] Odense Univ Hosp, Dept Breast Surg, Odense, Denmark
[6] Univ Southern Denmark, Dept Clin Res, Odense, Denmark
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.059
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
250P
引用
收藏
页码：S340 / S340
页数：1
相关论文
共 50 条
  • [1] FDG-PET/CT in high-risk primary breast cancer—a prospective study of stage migration and clinical impact
    Marianne Vogsen
    Jeanette Dupont Jensen
    Ivar Yannick Christensen
    Oke Gerke
    Anne Marie Bak Jylling
    Lisbet Brønsro Larsen
    Poul-Erik Braad
    Katrine Lydolph Søe
    Camilla Bille
    Marianne Ewertz
    Malene Grubbe Hildebrandt
    [J]. Breast Cancer Research and Treatment, 2021, 185 : 145 - 153
  • [2] FDG-PET/CT in high-risk primary breast cancer-a prospective study of stage migration and clinical impact
    Vogsen, Marianne
    Jensen, Jeanette Dupont
    Christensen, Ivar Yannick
    Gerke, Oke
    Jylling, Anne Marie Bak
    Larsen, Lisbet Bronsro
    Braad, Poul-Erik
    Soe, Katrine Lydolph
    Bille, Camilla
    Ewertz, Marianne
    Hildebrandt, Malene Grubbe
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2021, 185 (01) : 145 - 153
  • [3] FDG-PET/CT for diagnosing recurrent breast cancer - a prospective study of diagnostic accuracy and clinical impact
    Vogsen, Marianne
    Jensen, Jeanette
    Gerke, Oke
    Jylling, Anne Marie
    Asmussen, Jon
    Braad, Poul-Erik
    Thye-Roenn, Peter
    Soe, Katrine
    Ewertz, Marianne
    Hildebrandt, Malene
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [4] Male primary breast cancer found on FDG-PET/CT
    McEachen, James C.
    Kuo, Phillip H.
    [J]. CLINICAL NUCLEAR MEDICINE, 2008, 33 (09) : 630 - 632
  • [5] FDG-PET/CT predicts survival in high-risk Neuroblastoma
    Papathanasiou, N.
    Sullivan, K.
    Aldridge, M.
    Soderlund, T.
    Waddington, W.
    Gaze, M.
    Bomanji, J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S253 - S253
  • [6] FDG-PET and PET/CT in breast cancer staging
    Avril, Norbert
    Mather, Stephen J.
    Roylance, Rebecca
    [J]. BREAST CARE, 2007, 2 (06) : 372 - 377
  • [7] Role of FDG PET/CT in the preoperative staging of high-risk clinical early stage endometrial cancer
    Crivellaro, Cinzia
    Guerra, Luca
    Signorelli, Mauro
    Mapelli, Paola
    De Ponti, Elena
    Picchio, Maria
    Pirovano, Cecilia
    Milani, Rodolfo
    Messa, Cristina
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [8] Is FDG-PET/CT useful in initial evaluation of patients with clinical stage II breast cancer?
    Groheux, David
    Espie, Marc
    Vercellino, Laetitia
    Hamy, Anne-Sophie
    Giacchetti, Sylvie
    Berenger, Nathalie
    Misset, Jean-Louis
    Hindie, Elif
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [9] FDG-PET/CT for Primary Staging and Detection of Recurrence of Breast Cancer
    Groheux, David
    [J]. SEMINARS IN NUCLEAR MEDICINE, 2022, 52 (05) : 508 - 519
  • [10] Compairing FDG-PET/CT with MIBG scans for Staging of Relapse Stage IV High-Risk Neuroblastoma
    Fania, P.
    Quartuccio, N.
    Asaftei, S.
    Barat, V.
    Postini, A. M.
    Bianchi, M.
    Fagioli, F.
    Cistaro, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S252 - S252
12345